(3S)-1-(3-pyridinylmethyl)pyrrolidine-3-amine | 256526-96-2

• 分子结构分类: 有机化合物 - 有机氮化合物
• 英文名称: (3S)-1-(3-pyridinylmethyl)pyrrolidine-3-amine
• 英文别名: (3S)-1-(pyridin-3-ylmethyl)pyrrolidin-3-amine
• CAS: 256526-96-2
• 化学式: C₁₀H₁₅N₃
• 分子量: 177.249
• InChiKey: IILGAEIUCGHFMZ-JTQLQIEISA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -0.1
• 重原子数：
  13
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  42.2
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  (3S)-1-(3-pyridinylmethyl)pyrrolidine-3-amine 、 (2S)-1-(1,3-benzothiazol-2-yl)-2-piperidinecarboxylic acid 在 4-二甲氨基吡啶 作用下， 生成 (2S)-1-(1,3-benzothiazol-2-yl)-N-[(3S)-1-(3-pyridinylmethyl)pyrrolidin-3-yl]-2-piperidinecarboxamide
  参考文献：
  名称：

  Heterocyclic compounds as inhibitors of rotamase enzymes

  摘要：

  式（I）的化合物：其中A、Y、R、X、R1、R2、R3和R4如上所定义，是特定的FKBP-12和FKBP-52的旋转酶抑制剂。因此，这些化合物调节神经元再生和生长，可用于治疗由神经退行性疾病或其他涉及神经损伤的神经疾病引起的神经系统紊乱。

  公开号：

  US06372736B1

文献信息

• HETEROCYCLIC COMPOUNDS AS INHIBITORS OF ROTAMASE ENZYMES
  申请人：Pfizer Limited

  公开号：EP1100797A1

  公开（公告）日：2001-05-23
• US6372736B1
  申请人：——

  公开号：US6372736B1

  公开（公告）日：2002-04-16
• US6562964B1
  申请人：——

  公开号：US6562964B1

  公开（公告）日：2003-05-13
• [EN] HETEROCYCLIC COMPOUNDS AS INHIBITORS OF ROTAMASE ENZYMES<br/>[FR] COMPOSES HETEROCYCLIQUES INHIBITEURS D'ENZYMES ROTAMASE
  申请人：PFIZER LTD

  公开号：WO2000005232A1

  公开（公告）日：2000-02-03

  Compounds of the formula (I) wherein A is unbranched C3-C5 alkylene optionally substituted by C1-C6 alkyl; X is O, S, NH or N(C1-C6 alkyl); Y is O, S, NH or N(C1-C6 alkyl); R is a C-linked, 4- to 6-membered ring, non-aromatic, heterocyclic group containing one nitrogen heteroatom, said group being optionally substituted by 1, 2 or 3 substituent(s) each independently selected from C1-C6 alkyl, C2-C6 alkenyl, C3-C7 cycloalkyl, aryl, het, -CO2(C1-C6 alkyl), -CO(het), -CONR5R6 and -CO(aryl), said alkyl and alkenyl being optionally substituted by 1 or 2 substituent(s) each independently selected from C3-C7 cycloalkyl, aryl, het, -O(aryl), -O(C1-C2 alkylene) aryl, -CO(het), -CONR5R6 and -CO(aryl); are inhibitors of rotamase enzymes in particular FKBP-12 and FKBP-52. The compounds therefore moderate neuronal regeneration and outgrowth and can be used for treating neurological disorders arising from neurodegenerative diseases or other disorders involving nerve damage.
• Heterocyclic compounds as inhibitors of rotamase enzymes
  申请人：Pfizer INC

  公开号：US06372736B1

  公开（公告）日：2002-04-16

  Compounds of the formula (I): wherein A, Y, R, X, R1, R2, R3 and R4 are as defined above are inhibitors of rotamase enzymes in particular FKBP-12 and FKBP-52. The compounds therefore moderate neuronal regeneration and outgrowth and can be used for treating neurological disorders arising from neurodegenerative diseases or other disorders involving nerve damage.

  式（I）的化合物：其中A、Y、R、X、R1、R2、R3和R4如上所定义，是特定的FKBP-12和FKBP-52的旋转酶抑制剂。因此，这些化合物调节神经元再生和生长，可用于治疗由神经退行性疾病或其他涉及神经损伤的神经疾病引起的神经系统紊乱。